Loading...

ADVENZYMES Advanced Enzyme Technologies Ltd Changes in capital structure Announcement

dvnc

DVNZ

Advanced Enzyme Technologies Ltd

(ADVENZYMES)

2025 Announcement

Regulatory Compliance

Earnings Call Transcript

Conference call recording

Newspaper Publication

Earnings Release

Earnings Presentation

Statutory Auditor Reappoint...

Director Reappointment

Interim Dividend Deferral

Dividend recommendation

Audited results

Appointments and Reappointm...

Credit rating reaffirmation

Conference call

Board meeting intimation

Regulatory Compliance

Senior VP Resignation

Trading Window Closure

Credit rating assigned

Special dematerialization w...

Earnings Call Transcript

Conference Call

Newspaper Publication

Earnings Presentation

Earnings Release

Civil Litigation

Unaudited results

Conference Call

Audit Firm Conversion

Regulatory Compliance

Trading Window Closure

Earnings Call Transcript

Conference call recording

Unaudited results

Earnings Release

Earnings Presentation

Unaudited Financial Results

Unaudited results

Investor Conference Call

Share Transfer Update

Board Meeting Intimation

Compliance Certificate

Investor Presentation

Investor Meeting

Campaign Announcement

Earnings Call Transcript

Conference Call Update

Financial Results Update

Quarterly Earnings Release

Earnings Presentation

Investment Approved

Management Change

Solar Power Collaboration

Share Transfer Window

Share Transfer Notice

Compliance Certificate

New Subsidiary Informed

Annual Report Update

Newspaper Publication

Investor Meeting Scheduled

Investor Meetings

Analyst Meeting

Investor Meeting

Investor Meeting

Annual Compliance Report

Earnings Call Transcript

Investor Meeting

Investor Call Update

Financial Results Published

Earnings Presentation

Earnings Release

Dividend Announcement

Subsidiary Incorporation

Management Change

Conference Call

Compliance Certificate

Stock Options Granted

Equity Shares Allotment

Investor Meeting

Investor Meeting

Investor Meeting

Investor Meet Schedule

Investor Meetings

Investor Meeting Announced

Investor Meetings

Investor Meetings

Credit Rating Update

Earnings Call Transcript

Investor Meet Outcome

Financial Results Publication

Earnings Presentation

Q3 Earnings Report

Conference Call Scheduled

SEBI Compliance Certificate

Analyst Meeting

Investor Meeting

Equity Share Acquisition

Investor Meeting

Investor Meeting

New Corporation Formation

Formation of Starya Labs

Investor Meetings

Earnings Call Transcript

Conference Call Update

Financial Results Published

Quarterly Earnings

Earnings Presentation

Investment Update

Conference Call Notice

Regulatory Confirmation

Tax Penalty Order

Investor Meeting

Investor Meetings

Investor Meetings

Investor Meetings

Investor Meeting

Investor Meeting Scheduled

Investor Meeting

Compounding Charges Paid

Investor Meeting

Investor Meeting Scheduled

Q1 FY25 Results

Conference Call Update

Financial Results Published

Financial Results Announcement

Earnings Presentation

Conference Call

Newspaper Publication

Certificate Submission

Notice Publication

Newspaper Publication

Immovable Property Sale

AGM, Dividend Record Date &...

Meeting Intimation

Investor Meeting

Meeting Intimation

Investor Meetings

Meeting Intimation

Conference Call Transcript

Meeting Intimation

Meeting Intimation

Analyst Meeting

Financial Results Conferenc...

Compliance Report Submission

Dividend Tax Deduction

Newspaper Publication

Earnings Presentation

Financial Results Announcement

Conference Call

Board Meeting Notice

Compliance Certificate Subm...

Compliance Confirmation

Certificate Submission

Director Cessation

Meeting Intimation

Analyst/Investor Meeting

Meeting Intimation

Stake Acquisition

Legal Dispute Outcome

Earnings Call Transcripts

Meeting Schedule

Audio recording released

Financial Results

Earnings Presentation

Financial Results

Conference call

Acquisition of Stake

Certificate Received

Investor Meeting

Meeting Rescheduling

Penalty and Interest from G...

Analyst/Investor Meeting

Analyst/Investor Meeting

Analyst/Investor Meeting

Analyst / Investor Meet

Analyst/Investor Meetings

Analyst/Investor Meetings

Analyst/Investor Meeting

Investor Meeting

Conference Call Transcript

Closure of Subsidiary

Investor Call Recording Rel...

Financial Results Approval

Financial Results

Earnings Presentation

Conference Call

Certificate Submission

Investor Meeting

Analyst/Investor Meeting

Investor Meetings

Investor Meetings

Investor Meetings

Financial Statements

Analyst / Investor Meeting

One-to-One meeting

Conference Call

Stock Options Grant

Financial Statements

Financial Statements

Conference call

Certificate Submission

Financial Statements, AGM A...

Financial Statements, Earni...

Financial Statements, Earni...

Analyst / Investor Meet

Analyst/Investor Meet

Virtual one-to-one

Virtual Meeting

Analyst/Investor Meeting

Scheduled Meetings

Analyst/Investor Meet

Analyst / Institutional Inv...

Investor Meetings

Annual Secretarial Complian...

Analyst / Investor Meet

Notice of Interim Dividend ...

Financial Statements

Financial Statements

Financial Statements Approv...

Financial Results

Analyst/Investor Meeting

External Links:

Data:

On October 7, 2025, Advanced Enzyme Technologies Ltd allotted 45,650 equity shares under its Employee Stock Option Scheme 2022, increasing its paid-up share capital to 22,38,53,600.

AI Assistant

Advanced Enzyme Technologies Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.